AIM CLINICAL APPROPRIATENESS GUIDELINES FOR RADIATION ONCOLOGY
The foundation of our solution platform for specialty benefits management is our clinical appropriateness guidelines.
AIM Clinical Appropriateness Guidelines for Radiation Oncology are developed through a rigorous process integrating evidence-based literature with expert physician review. Included below are guidelines for radiation therapy and proton beam therapy.
AIM Clinical Appropriateness Guidelines for Radiation Oncology
The treatments addressed in the AIM Clinical Appropriateness Guidelines for Radiation Oncology include brachytherapy, intensity-modulated radiation therapy, stereotactic body radiation therapy, and stereotactic radiosurgery.
OPEN THE GUIDELINES FOR RADIATION ONCOLOGY
COMING SOON RADIATION ONCOLOGY GUIDELINES EFFECTIVE AS OF February 09, 2020
AIM Clinical Appropriateness Guidelines for Proton Beam Therapy
The treatment addressed in the AIM Clinical Appropriateness Guidelines for Proton Beam Treatment is proton beam therapy, also known as proton radiation therapy or proton radiotherapy.
OPEN THE GUIDELINES FOR PROTON BEAM THERAPY
Trouble viewing the guidelines?
To open our guidelines, your computer needs Adobe Reader, a free and trusted software that allows you to view PDFs.
CLINICAL GUIDELINES ACCESS
BY CLICKING ON THE “I ACCEPT” BUTTON BELOW, I ACKNOWLEDGE ACCEPTANCE OF THE FOLLOWING TERMS AND CONDITIONS FOR ACCESS AND USE OF THE CLINICAL GUIDELINES:
AIM Specialty Health has developed proprietary Diagnostic Imaging Utilization Management Clinical Guidelines (together with any updates, referred to collectively as the “Guidelines”). The Guidelines are designed to evaluate and direct the appropriate utilization of high technology diagnostic imaging services. They are based on data from the peer-reviewed scientific literature, from criteria developed by specialty societies and from guidelines adopted by other health care organizations. Access to these Guidelines is being provided for informational purposes only. AIM is under no obligation to update its Guidelines. Therefore, these Guidelines may be out of date.
The Guidelines are protected by copyright of AIM as permitted by and to the full extent of the law. These rights are not released, transferred, or assigned as a result of allowing access. You agree that you do not have any ownership rights to the Guidelines and you are expressly prohibited from selling, assigning, leasing, licensing, reproducing or distributing the Guidelines, unless authorized in writing by AIM.
The Guidelines do not constitute medical advice and/or medical care, and do not guarantee results or outcomes. The Guidelines are not a substitute for the experience and judgment of a physician or other health care professionals. Any clinician seeking to apply or consult the Guidelines is expected to use independent medical judgment in the context of individual clinical circumstances to determine any patient’s care or treatment. The Guidelines do not address coverage, benefit or other plan specific issues.
The Guidelines are provided “as is” without warranty of any kind, either expressed or implied.
AIM disclaims all responsibility for any consequences or liability attributable or related to any use, nonuse or interpretation of information contained in the Guidelines.